PAA 0.00% 20.0¢ pharmaust limited

Dr Richard Mollard Interview 17 Jul 2020, page-33

  1. 11,801 Posts.
    lightbulb Created with Sketch. 5979
    Never heard Richard use the words "Fantastic" ever ...

    We can now enjoy Safety and Knowledge of Mechanism of Action . MPL approved for Human Use in 30 Countries already.
    Preparing a Pre-clinical summary ,,, for testing in Human Patients.

    Cov Mechanism of Action Inhibits Virus replication , secondary infection control 95%

    Phase II K9 Cancer Treatment demonstrated 60% regression , 1 Tumor back to stasis tissue

    Dossier being prepared for K9 Phase II Data
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $89.00M
Open High Low Value Volume
19.5¢ 20.0¢ 19.5¢ $101.0K 508.8K

Buyers (Bids)

No. Vol. Price($)
7 420397 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 8821 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.